These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 8648097)

  • 41. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
    Joseph LF; Ezhevsky S; Scott DW
    Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of the role of G1/S cell cycle mediators in cellular senescence.
    Afshari CA; Vojta PJ; Annab LA; Futreal PA; Willard TB; Barrett JC
    Exp Cell Res; 1993 Dec; 209(2):231-7. PubMed ID: 8262140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of the cyclin-dependent kinase inhibitor p27Kip1 in negative signaling through the antigen-receptor of B lymphocytes.
    Han H; Nomura T; Honjo T; Tsubata T
    Leukemia; 1997 Apr; 11 Suppl 3():367-9. PubMed ID: 9209392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase.
    Chen E; Li CC
    Biochem Biophys Res Commun; 1998 Aug; 249(3):728-34. PubMed ID: 9731206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW
    J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fos proteins can act as negative regulators of cell growth independently of the fos transforming pathway.
    Balsalobre A; Jolicoeur P
    Oncogene; 1995 Aug; 11(3):455-65. PubMed ID: 7630629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell cycle-specific induction of Cdk2 expression in B lymphocytes following antigen receptor cross-linking.
    Tanguay DA; Chiles TC
    Mol Immunol; 1994 Jun; 31(9):643-9. PubMed ID: 8028598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.
    Songia S; Mortellaro A; Taverna S; Fornasiero C; Scheiber EA; Erba E; Colotta F; Mantovani A; Isetta AM; Golay J
    J Immunol; 1997 Apr; 158(8):3987-95. PubMed ID: 9103470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilization of cyclin E and cdk2 mRNAs at G1/S transition in Rat-1A cells emerging from the G0 state.
    Oda S; Nishida J; Nakabeppu Y; Sekiguchi M
    Oncogene; 1995 Apr; 10(7):1343-51. PubMed ID: 7731685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granzyme B induces apoptosis and cyclin A-associated cyclin-dependent kinase activity in all stages of the cell cycle.
    Shi L; Chen G; He D; Bosc DG; Litchfield DW; Greenberg AH
    J Immunol; 1996 Sep; 157(6):2381-5. PubMed ID: 8805636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells.
    Modiano JF; Domenico J; Szepesi A; Lucas JJ; Gelfand EW
    J Biol Chem; 1994 Dec; 269(52):32972-8. PubMed ID: 7806527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The regulation of p27Kip1 expression following the polyclonal activation of murine G0 T cells.
    Kwon TK; Buchholz MA; Ponsalle P; Chrest FJ; Nordin AA
    J Immunol; 1997 Jun; 158(12):5642-8. PubMed ID: 9190912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth.
    Ishida T; Kobayashi N; Tojo T; Ishida S; Yamamoto T; Inoue J
    J Immunol; 1995 Dec; 155(12):5527-35. PubMed ID: 7499834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.
    Wei GL; Krasinski K; Kearney M; Isner JM; Walsh K; Andrés V
    Circ Res; 1997 Mar; 80(3):418-26. PubMed ID: 9048663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.
    Lu S; Tsai SY; Tsai MJ
    Cancer Res; 1997 Oct; 57(20):4511-6. PubMed ID: 9377562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes.
    Takase K; Terada N; Lucas JJ; Gelfand EW
    J Cell Physiol; 1995 Feb; 162(2):246-55. PubMed ID: 7529768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins.
    Ohkubo Y; Kishimoto T; Nakata T; Yasuda H; Endo T
    Exp Cell Res; 1994 Sep; 214(1):270-8. PubMed ID: 8082730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas.
    Miyatake S; Nakano H; Park SY; Yamazaki T; Takase K; Matsushime H; Kato A; Saito T
    J Exp Med; 1995 Aug; 182(2):401-8. PubMed ID: 7629502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
    Sun W; Lee DK; Lee CC; Kim K
    Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.